K-numberK251411
Device nameChemfort Female Luer Lock Adaptor
ApplicantSimplivia Healthcare , Ltd.
Product codeONB
Device classClass II
Decision dateAug 5, 2025
DecisionSubstantially Equivalent
Regulation880.5440
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Chemfort Female Luer Lock Adaptor is a single-use, sterile closed system transfer device that mechanically prevents the release of hazardous and antineoplastic drugs in vapor, aerosol, or liquid form during drug preparation and administration. It minimizes exposure to healthcare personnel and the environment while preventing microbial and airborne contaminants from entering the drug or fluid path for up to 7 days. The device connects male luer connections to Chemfort syringe adaptors and allows safe drug transfer between syringes or connection to IV sets.

Technological characteristics

The proposed device differs from the predicate device K192866 only in its luer connection type: this device has a female luer lock connection on the distal end (connecting to any standard male luer), whereas the predicate has a male luer lock connection (connecting to any standard female luer). Both devices use identical polypropylene and polyisoprene materials, employ the same septum-to-septum contact safety mechanism with mechanical snap connections, support up to 10 proximal reconnections, and are sterilized via ethylene oxide to SAL 10-6.

Test standards cited

ISO 80369-7:2021 (small-bore connectors for intravascular applications), ISO 10993-1 through 10993-18 (biocompatibility evaluation), ISO 11135:2014 and ISO 11607-1:2019 (sterilization and packaging), ISO 14971:2019 (risk management), USP <788> (particulate matter), USP <85> (bacterial endotoxins), and USP <161> (transfusion and infusion assemblies).

Substantial equivalence argument

The device is substantially equivalent because it shares identical indications for use, raw materials, principles of operation, technological features, and sterilization methods with the predicate device. The only difference is the luer connection gender (female versus male), but performance testing to ISO 80369-7:2021 demonstrates this difference does not raise new safety or effectiveness issues. All other design features, biocompatibility, manufacturing, and functional testing are equivalent to the predicate device.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →